“Three new Levaquin Lawsuits have been filed against Johnson & Johnson and Ortho-McNeil-Janssen Pharmaceuticals in New Jersey state court, joining other similar cases filed in state and federal courts throughout the country, alleging that the antibiotic caused plaintiffs to suffer painful tendon ruptures.
Levaquin (levofloxacin) was first approved by the FDA in December 1996 to prevent infection by stopping reproduction of bacteria. However, a number of users have developed Levaquin tendon ruptures and tendonitis as a side effect of the medication, which the complaints allege Johnson & Johnson failed to adequately warn about.”
Reading Tea Leaves by Randy Wilson 
Leave a Reply